EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Chemoresistance in Ovarian Cancer and Association with Circadian Rhythm

Fatma Seher Pektopal iD, Selen Kum Özşengezer iD, Zekiye Sultan Altun iD

Reproductive Sciences · 2026-06 · 33 (6) · 1079-1090

DOI: 10.1007/s43032-026-02093-9 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Reproductive Sciences, online erschienen am 04.05.2026. Verfasst von Fatma Seher Pektopal und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Basic Oncology, Oncology Institute, Dokuz Eylül University, Izmir, Turkey. f.seherpektopal@gmail.com. Hauptthemen laut MEDLINE: Ovarian Neoplasms, Circadian Rhythm, Drug Resistance, Neoplasm, Antineoplastic Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Dokuz Eylül University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ovarian cancer (OC) accounts for a significant percentage of cancer-related deaths in women worldwide. A small proportion of ovarian cancers, usually in women under 40, originate from germ cells and stromal cells within the ovary, but the vast majority are epithelial malignancies. The preferred treatment for ovarian malignancies consists of platinum-based chemotherapy and surgical intervention. Chemoresistance in ovarian cancer is a complex problem that significantly impedes tratment efficacy. Many pathways contribute to this resistance, including genetic factors, tumor microenvironment interactions, and lifestyle variables such as obesity. Understanding these mechanisms is crucial for developing effective treatment solutions. The circadian rhythm, or circadian clock, regulates the sleep–wake cycle, body temperature, hormone secretion, metabolism, and many physiological processes. Circadian genes are highly expressed in the ovaries, which regulate ovulation. Disruption of circadian rhythm asociated with many risk factors for ovarian cancer. This article examines the relationship between circadian rhythm and chemotherapy resistance in ovarian cancer, and reviews circadian rhythm to reduce chemotherapy resistance in this context.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ovarian NeoplasmsCircadian RhythmDrug Resistance, NeoplasmAntineoplastic AgentsHumansFemaleAnimals

Stichwörter der Autor:innen

ChemoresistanceCircadian rhythmCisplatinOvarian cancer

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • Department of Basic Oncology, Oncology Institute, Dokuz Eylül University, Izmir, Turkey. f.seherpektopal@gmail.com.
  • Department of Basic Oncology, Oncology Institute, Dokuz Eylül University, Izmir, Turkey.

ORCID-Profile: Fatma Seher Pektopal, Selen Kum Özşengezer, Zekiye Sultan Altun

Förderung

  • Dokuz Eylül University

Zitieren

APA

Pektopal, F. S., Kum Özşengezer, S., & Altun, Z. S. (2026). Chemoresistance in Ovarian Cancer and Association with Circadian Rhythm. Reproductive Sciences, 33(6), 1079-1090. https://doi.org/10.1007/s43032-026-02093-9

Vancouver

Pektopal FS, Kum Özşengezer S, Altun ZS. Chemoresistance in Ovarian Cancer and Association with Circadian Rhythm. Reproductive Sciences. 2026;33(6):1079-1090. doi:10.1007/s43032-026-02093-9

BibTeX
@article{Pektopal2026,
  author = {Pektopal, Fatma Seher and Kum Özşengezer, Selen and Altun, Zekiye Sultan},
  title = {Chemoresistance in Ovarian Cancer and Association with Circadian Rhythm},
  journal = {Reproductive Sciences},
  year = {2026},
  volume = {33},
  number = {6},
  pages = {1079--1090},
  doi = {10.1007/s43032-026-02093-9}
}
Kostenlos starten →